FindTrial
Sign In

Clinical studies of breast cancer of abnormal methylation of XRCC2, DAPK gene

Clinical studies of breast cancer of abnormal methylation of XRCC2, DAPK gene

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-12002352
Enrollment
Unknown
Registered
2012-06-10
Start date
2010-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:
Index test:

Sponsors

Shuyang People'Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Shuyang People's Hospital from January 2010 to December 2012, patient who pathological confirmed breast cancer, 100 specimens of breast cancer tissues and paired adjacent noncancerous specimens

Exclusion criteria

Exclusion criteria: patient who pathological unconfirmed breast cancer

Design outcomes

Primary

MeasureTime frame
Bisulfite sequencing;Quantitative RT-PCR analysis;—

Countries

China

Contacts

Public ContactGuangxiu Xie,Ye-Ting Zhou
Gxie88@hotmail.com+86 18762164533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026